Uterine adenofibroma and endometrial stromal sarcoma associated with tamoxifen therapy: MR findings.
Comput Med Imaging Graph
; 30(5): 315-8, 2006 Jul.
Article
in En
| MEDLINE
| ID: mdl-16890405
ABSTRACT
Tamoxifen therapy may result in a variety of endometrial proliferative lesions, including adenofibroma and endometrial stromal sarcoma (ESS). This report describes the MR findings of adenofibroma and ESS associated with tamoxifen therapy. When MRI demonstrates a uterine mass appearing as a heterogeneous mass in the endometrium or myometrium, adenofibroma and ECC must be considered as rare, but possible, diagnoses.
Search on Google
Database:
MEDLINE
Main subject:
Tamoxifen
/
Uterine Neoplasms
/
Magnetic Resonance Imaging
/
Adenofibroma
/
Sarcoma, Endometrial Stromal
Type of study:
Diagnostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
Language:
En
Journal:
Comput Med Imaging Graph
Journal subject:
DIAGNOSTICO POR IMAGEM
Year:
2006
Type:
Article
Affiliation country:
Japan